Biomedical Engineering Reference
In-Depth Information
[21] He YK, �ui VW, Baar J, Wang �, Shurin M, Almonte C, et al. Potentiation of E7 anti-
sense RNA-induced antitumor immunity by co-delivery of IL-12 gene in HPV16 DNA-
positive mouse tumor. Gene Ther 1998;5:1462-71.
[22] Zheng H, Brigham K�, Gao X. Expression and pharmacokinetics of intratracheally
administered naked DNA in mouse airways. Mol Ther 2000;1:S22.
[23] Glasspool MJ, Malone RW. Marked enhancement of direct respiratory tissue transfection
by aurintricarboxylic acid. Hum Gene Ther 1999;10:1703-13.
[24] Hashida M, Mahato RI, Kawabata K, Miyao T, Nishikawa M, Takakura Y. Pharmacokinetics
and targeted delivery of proteins and genes. J Control Release 1996;41:91-7.
[25] Budker V, Zhang G, Knechtle S, Wolff JA. Naked DNA delivered intraportally expresses
efficiently in hepatocytes. Gene Ther 1996;3:593-8.
[26] Budker V, Zhang G, Danko I, Williams P, Wolff J. The efficient expression of intravascu-
larly delivered DNA in rat muscle. Gene Ther 1998;5:272-6.
[27] Kameda S, Maruyama H, Higuchi N, Iino N, Nakamura G, Miyazaki J, et al. Kidney-
targeted naked DNA transfer by retrograde injection into the renal vein in mice. Biochem
Biophys Res Commun 2004;314:390-5.
[28] Hao J, �i SK, Kao. WYW, �iu C-Y. Gene delivery to cornea. Brain Res Bull
2010;81:256-61.
[29] Stechschulte SU, Joussen AM, von Recum HA, Poulaki V, Moromizato Y, Yuan J, et al.
Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol
Vis Sci 2001;42:1975-9.
[30] Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, et al. Corneal avascularity
is due to soluble VEGF receptor-1. Nature 2006;443:993-7.
[31] Singh N, Higgins E, Amin S, Jani P, Richter E, Patel A, et al. Unique homologous siRNA
blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and
regresses murine corneal neovascularization. Cornea 2007;26:65-72.
[32] Budker V, Budker T, Zhang G, Subbotin V, �oomis A, Wolff JA. Hypothesis: naked
plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med
2000;2:76-88.
[33] Chang DC, Reese TS. Changes in membrane structure induced by electroporation as
revealed by rapid-freezing electron microscopy. Biophys J 1990;58:1-12.
[34] Melkonyan H, Sorg C, Klempt M. Electroporation efficiency in mammalian cells is
increased by dimethyl sulfoxide (DMSO). Nucleic Acids Res 1996;24:4356-7.
[35] Yang TA, Heiser WC, Sedivy JM. Efficient in situ electroporation of mammalian cells
grown on microporous membranes. Nucleic Acids Res 1995;23:2803-10.
[36] Zhang �, Nolan E, Kreitschitz S, Rabussay DP. Enhanced delivery of naked DNA to the
skin by non-invasive in vivo electroporation. Biochim Biophys Acta 2002;1572:1-9.
[37] Tjelle TE, Salte R, Mathiesen I, Kjeken R. A novel electroporation device for gene deliv-
ery in large animals and humans. Vaccine 2006;24:4667-70.
[38] Huang KS, �i M, Su CC, Huang HH, Fang CS, �in YC. Enhancement of an electropora-
tion system for gene delivery using electrophoresis with planar electrodes. Conference
proceedings: Annual International Conference of the IEEE Engineering in Medicine and
Biology Society. Abstract Book; 2005, 1. p. 522-5.
[39] Gothelf A, Mir �M, Gehl J. Electrochemotherapy: results of cancer treatment using
enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003;29:371-87.
[40] Bigey P, Bureau MF, Scherman D. In vivo plasmid DNA electrotransfer. Curr Opin
Biotechnol 2002;13:443-7.
[41] Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy
and research. Acta Physiol Scand 2003;177:437-47.
Search WWH ::




Custom Search